DENGUE Antiviral Immunofluorescence staining Protocol v1

This protocol describes immunofluorescence staining of fixed SARS-CoV-2 infected cells using IC7C7 primary antibody (produced in house against SARS-CoV-2 NP) and Alexa Fluor 488-conjugated secondary antibody. The procedure results in fluorescently labeled infected cells for quantification of viral infection.

Authors

Institutions

Publication Details

Published
2025-02-27
DOI
https://doi.org/10.17504/protocols.io.8epv52yb6v1b/v1
Primary Topic
Cytomegalovirus and herpesvirus research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

DENGUE Antiviral Immunofluorescence staining Protocol v1

Briana L McGovern
Cytomegalovirus and herpesvirus research
article

DENGUE Antiviral Immunofluorescence staining Protocol v1

Briana L McGovern
article en

Abstract

This protocol describes immunofluorescence staining of fixed SARS-CoV-2 infected cells using IC7C7 primary antibody (produced in house against SARS-CoV-2 NP) and Alexa Fluor 488-conjugated secondary antibody. The procedure results in fluorescently labeled infected cells for quantification of viral infection.

Icahn School of Medicine at Mount Sinai (US)
National Institutes of Health, National Institute of Allergy and Infectious Diseases
Openalex Percentile: Top 73%
Cytomegalovirus and herpesvirus research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

DENGUE Antiviral Immunofluorescence staining Protocol v1 — Briana L McGovern · (2025) | TGRS Research Map | TGRS